Obbligazioni 4502
Di seguito è riportato l'elenco delle obbligazioni societarie TAKEDA PHARMACEUTICAL CO LTD. Gli investitori spesso optano per le obbligazioni di una società per la loro maggiore stabilità in tempi di volatilità del mercato. Studia i prezzi, i rendimenti e altre statistiche per trovare un investimento affidabile.
Simbolo | YTM % | Prezzo % | Cedola % | Data di maturazione | Importo in eccesso | Valore nominale | Importo min. denominazione | Emittente |
|---|---|---|---|---|---|---|---|---|
 TKPH5841810Takeda Pharmaceutical Company Limited 5.8% 05-JUL-2064 | 5,45% | 106,59% | 5,80% | 2064-07-05 | 500 M USD | 1.000,00 USD | 200.000,00 USD | Takeda Pharmaceutical Co., Ltd. |
| TKPH5841809Takeda Pharmaceutical Company Limited 5.65% 05-JUL-2054 | 5,31% | 105,64% | 5,65% | 2054-07-05 | 600 M USD | 1.000,00 USD | 200.000,00 USD | Takeda Pharmaceutical Co., Ltd. |
| TKPH5841808Takeda Pharmaceutical Company Limited 5.65% 05-JUL-2044 | 5,17% | 106,25% | 5,65% | 2044-07-05 | 800 M USD | 1.000,00 USD | 200.000,00 USD | Takeda Pharmaceutical Co., Ltd. |
| TTKPH4369980Baxalta Incorporated 5.25% 23-JUN-2045 | 5,17% | 101,07% | 5,25% | 2045-06-23 | 500,407 M USD | 1.000,00 USD | 2.000,00 USD | Baxalta, Inc. |
| TKPH5010046Takeda Pharmaceutical Company Limited 3.025% 09-JUL-2040 | 4,95% | 78,17% | 3,03% | 2040-07-09 | 1,5 B USD | 1.000,00 USD | 200.000,00 USD | Takeda Pharmaceutical Co., Ltd. |
| TKPH5010047Takeda Pharmaceutical Company Limited 3.175% 09-JUL-2050 | 4,92% | 72,51% | 3,18% | 2050-07-09 | 2 B USD | 1.000,00 USD | 200.000,00 USD | Takeda Pharmaceutical Co., Ltd. |
| TKPH5010048Takeda Pharmaceutical Company Limited 3.375% 09-JUL-2060 | 4,86% | 71,57% | 3,38% | 2060-07-09 | 1 B USD | 1.000,00 USD | 200.000,00 USD | Takeda Pharmaceutical Co., Ltd. |
| TKPH5841807Takeda Pharmaceutical Company Limited 5.3% 05-JUL-2034 | 4,71% | 104,69% | 5,30% | 2034-07-05 | 1,1 B USD | 1.000,00 USD | 200.000,00 USD | Takeda Pharmaceutical Co., Ltd. |
| TTKPH4370840Baxalta Incorporated 4.0% 23-JUN-2025 | 4,53% | 99,48% | 4,00% | 2025-06-23 | 800,169 M USD | 1.000,00 USD | 2.000,00 USD | Baxalta, Inc. |
| TKPH4770188Takeda Pharmaceutical Company Limited 5.0% 26-NOV-2028 | 4,27% | 102,80% | 5,00% | 2028-11-26 | 1,727 B USD | 1.000,00 USD | 200.000,00 USD | Takeda Pharmaceutical Co., Ltd. |
| TKPH5010045Takeda Pharmaceutical Company Limited 2.05% 31-MAR-2030 | 4,22% | 89,25% | 2,05% | 2030-03-31 | 2,5 B USD | 1.000,00 USD | 200.000,00 USD | Takeda Pharmaceutical Co., Ltd. |
| UUS82481LAD1SHIRE ACQUIST.I.IE 16/26 | 4,03% | 98,40% | 3,20% | 2026-09-23 | 1,5 B USD | 1.000,00 USD | 2.000,00 USD | Shire Acquisitions Investments Ireland DAC |
| TKDBTAKEDA PHARMA. 20/40 | 3,72% | 78,94% | 2,00% | 2040-07-09 | 1 B EUR | 1.000,00 EUR | 100.000,00 EUR | Takeda Pharmaceutical Co., Ltd. |
| XS219734964TAKEDA PHARMA. 20/32 | 3,20% | 87,31% | 1,38% | 2032-07-09 | 1 B EUR | 1.000,00 EUR | 100.000,00 EUR | Takeda Pharmaceutical Co., Ltd. |
| XS184344939TAKEDA PHARMA.18/30 REGS | 3,13% | 99,25% | 3,00% | 2030-11-21 | 1,5 B EUR | 1.000,00 EUR | 100.000,00 EUR | Takeda Pharmaceutical Co., Ltd. |
| XS219734859TAKEDA PHARMA. 20/29 | 2,97% | 91,18% | 1,00% | 2029-07-09 | 850 M EUR | 1.000,00 EUR | 100.000,00 EUR | Takeda Pharmaceutical Co., Ltd. |
| XS184344912TAKEDA PHARMA. 18/26 REGS | 2,93% | 98,56% | 2,25% | 2026-11-21 | 1,5 B EUR | 1.000,00 EUR | 100.000,00 EUR | Takeda Pharmaceutical Co., Ltd. |
| XS219734832TAKEDA PHARMA. 20/27 | 2,85% | 94,35% | 0,75% | 2027-07-09 | 750 M EUR | 1.000,00 EUR | 100.000,00 EUR | Takeda Pharmaceutical Co., Ltd. |
| TKPH4770186Takeda Pharmaceutical Company Limited 5.0% 26-NOV-2028 | 0,96% | 116,57% | 5,00% | 2028-11-26 | 22,685 M USD | 1.000,00 USD | 200.000,00 USD | Takeda Pharmaceutical Co., Ltd. |
| SSHPG4260178Baxalta Incorporated 4.0% 23-JUN-2025 | — | — | 4,00% | 2025-06-23 | 303 K USD | 1.000,00 USD | 2.000,00 USD | Baxalta, Inc. |
| TKPH4770187Takeda Pharmaceutical Company Limited 5.0% 26-NOV-2028 | — | — | 5,00% | 2028-11-26 | 22,685 M USD | 1.000,00 USD | 200.000,00 USD | Takeda Pharmaceutical Co., Ltd. |